Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C L Grines

Showing results (101-110 of 119) with videos related to

Pageof 12
Sort By:
Journal of the American College of Cardiology|May 1, 1996
Prospective, randomized trial of prolonged intracoronary urokinase infusion for chronic total occlusions in native coronary arteriesF J Zidar, B M Kaplan, W W O'Neill, et al.
The American Journal of Cardiology|October 1, 1996
Poloxamer-188 as an adjunct to primary percutaneous transluminal coronary angioplasty for acute myocardial infarctionJ H O'Keefe, C L Grines, M A DeWood, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|June 22, 1999
Local intramural heparin delivery during primary angioplasty for acute myocardial infarction: results of the Local PAMI Pilot StudyP Esente, A V Kaplan, J K Ford, et al.
Journal of the American College of Cardiology|March 18, 1999
Long-term outcome after primary angioplasty: report from the primary angioplasty in myocardial infarction (PAMI-I) trialC M Nunn, W W O'Neill, D Rothbaum, et al.
Journal of the American College of Cardiology|May 1, 1996
A randomized trial of low osmolar ionic versus nonionic contrast media in patients with myocardial infarction or unstable angina undergoing percutaneous transluminal coronary angioplastyC L Grines, T L Schreiber, V Savas, et al.
Circulation|August 1, 1996
Beneficial effects of RheothRx injection in patients receiving thrombolytic therapy for acute myocardial infarction. Results of a randomized, double-blind, placebo-controlled trialG L Schaer, L J Spaccavento, K F Browne, et al.
The American Journal of Cardiology|July 1, 1996
Influence of acute myocardial infarction location on in-hospital and late outcome after primary percutaneous transluminal coronary angioplasty versus tissue plasminogen activator therapyG W Stone, C L Grines, K F Browne, et al.
The New England Journal of Medicine|December 23, 1999
Coronary angioplasty with or without stent implantation for acute myocardial infarction. Stent Primary Angioplasty in Myocardial Infarction Study GroupC L Grines, D A Cox, G W Stone, et al.
Catheterization and Cardiovascular Diagnosis|December 1, 1996
Outcome of different reperfusion strategies in patients with former contraindications to thrombolytic therapy: a comparison of primary angioplasty and tissue plasminogen activator. Primary Angioplasty in Myocardial Infarction (PAMI) InvestigatorsG W Stone, C L Grines, K F Browne, et al.
European Heart Journal|April 2, 2002
Clinical characteristics and outcome of patients with early (<2 h), intermediate (2-4 h) and late (>4 h) presentation treated by primary coronary angioplasty or thrombolytic therapy for acute myocardial infarctionF Zijlstra, A Patel, M Jones, et al.
Pageof 12

Showing results (101-110 of 119) with videos related to

Sort By:
Pageof 12
Journal of the American College of Cardiology|May 1, 1996
Prospective, randomized trial of prolonged intracoronary urokinase infusion for chronic total occlusions in native coronary arteriesF J Zidar, B M Kaplan, W W O'Neill, et al.
The American Journal of Cardiology|October 1, 1996
Poloxamer-188 as an adjunct to primary percutaneous transluminal coronary angioplasty for acute myocardial infarctionJ H O'Keefe, C L Grines, M A DeWood, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|June 22, 1999
Local intramural heparin delivery during primary angioplasty for acute myocardial infarction: results of the Local PAMI Pilot StudyP Esente, A V Kaplan, J K Ford, et al.
Journal of the American College of Cardiology|March 18, 1999
Long-term outcome after primary angioplasty: report from the primary angioplasty in myocardial infarction (PAMI-I) trialC M Nunn, W W O'Neill, D Rothbaum, et al.
Journal of the American College of Cardiology|May 1, 1996
A randomized trial of low osmolar ionic versus nonionic contrast media in patients with myocardial infarction or unstable angina undergoing percutaneous transluminal coronary angioplastyC L Grines, T L Schreiber, V Savas, et al.
Circulation|August 1, 1996
Beneficial effects of RheothRx injection in patients receiving thrombolytic therapy for acute myocardial infarction. Results of a randomized, double-blind, placebo-controlled trialG L Schaer, L J Spaccavento, K F Browne, et al.
The American Journal of Cardiology|July 1, 1996
Influence of acute myocardial infarction location on in-hospital and late outcome after primary percutaneous transluminal coronary angioplasty versus tissue plasminogen activator therapyG W Stone, C L Grines, K F Browne, et al.
The New England Journal of Medicine|December 23, 1999
Coronary angioplasty with or without stent implantation for acute myocardial infarction. Stent Primary Angioplasty in Myocardial Infarction Study GroupC L Grines, D A Cox, G W Stone, et al.
Catheterization and Cardiovascular Diagnosis|December 1, 1996
Outcome of different reperfusion strategies in patients with former contraindications to thrombolytic therapy: a comparison of primary angioplasty and tissue plasminogen activator. Primary Angioplasty in Myocardial Infarction (PAMI) InvestigatorsG W Stone, C L Grines, K F Browne, et al.
European Heart Journal|April 2, 2002
Clinical characteristics and outcome of patients with early (<2 h), intermediate (2-4 h) and late (>4 h) presentation treated by primary coronary angioplasty or thrombolytic therapy for acute myocardial infarctionF Zijlstra, A Patel, M Jones, et al.
Pageof 12